Arkolith/Insider Trading/COLL/Form 4

Dreyer Scott

EVP & Chief Commercial OfficerCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Aug 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$626K
Net Open-Market Flow
-$626K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Option exercise(M)16K$21.34$350K120K
Aug 18, 2025Sell(S)16K$38.21$626K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 18, 2025Option exercise(M)16K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-014766) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML